|[October 11, 2013]
Anthony Viscogliosi to address World Obesity Crisis at Cleveland Clinic's Medical Innovation Summit on October 14-16
NEW YORK --(Business Wire)--
Anthony G. Viscogliosi, a prominent figure in the field of orthopedic
devices, is to address next week's 11th Annual Medical Innovation Summit
in Cleveland on new technologies and education programs designed to aid
and treat millions of patients worldwide diagnosed as obese and living
with advanced forms of diabetes. The annual event is organized by
Cleveland Clinic Innovations, ranked by the industry as one of the
world's top four leaders in healthcare corporate venturing. Mr.
Viscogliosi, Principal of Viscogliosi Brothers, LLC in New York, is the
only presenter from the orthopedics industry among more than 50
healthcare executives, investors and physicians speaking at the
three-day event beginning on Monday, October 14. The event has attracted
more than 1,000 clinicians, investors and medical industry executives
and marks the opening of the newly completed Cleveland Convention Center.
"The well-established link between obesity, diabetes, and orthopedic
disease is a salient issue among patients, physicians, providers,
payers, and policymakers. Obesity now affects over 500 million patients
worldwide, predisposing them to severe fracture patterns in the spine,
pelvis, long bones, as well as the upper and lower extremities(1).
These patients tend to seek hip and knee replacements more than a decade
earlier than non-obese patients," Mr. Viscogliosi noted.
According to a study by diabetes specialists Care Services, Inc., Type
II diabetics, of whom up to 90% may also be obese, face radical surgery
due to impaired circulation and nerve function, an infection.
"Our mission in orthopedics is to raise awareness of these findings and
deliver innovative bone and joint treatments that can prevent amputation
and help restore anatomical form, function and motion," Mr. Viscogliosi
According to the International Diabetes Federation,(4) 4.8
million people died of the disease in 2012 and the number of Americans
suffering from diabetes will grow from 24 million in 2012 to nearly 30
million in 2030 - far outpacing the rate of US population growth.
Diabetes is no longer confined to the US. Six of the world's top ten
nations most affected by diabetes are in the Middle East and North
Africa. However, 20 percent of all adults with diabetes are in
South-East Asia, notably 60 million in India and more than 90 million in
"What's clear beyond the statistics," Mr. Viscogliosi added, "is that
obesity and diabetes have become a major global health problem. The pace
of medical innovation must accelerate to meet this challenge.
Implementation of life-changing medical solutions and global patient
awareness is fundamental to the successful, long-term management of what
is now a global health problem."
 World Health Organization
 "Impact of Obesity on Orthopaedics" by Sanjeev
Sabharwal, MD, and Michael Z. Root. The Journal of Bone & Joint
 Care Services, Inc: http://www.diabeticcareservices.com/diabetes-education/diabetes-and-obesity
 International Diabetes Federation
About Viscogliosi Brothers, LLC (VB): Established by Marc R.
Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York
City, in 1999, VB was the first venture capital/private equity and
merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm, with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies.
VB has worldwide surgeon, industry and trade relationships and
significant financial expertise in the musculoskeletal/orthopedic sector.
For more information about VB please visit: www.vbllc.com
[ Back To Technology News's Homepage ]